Crinetics Pharmaceuticals, Inc.
CRNX2026/9/1 下市- 產業
- Pharmaceutical Preparations
- SEC CIK
- 0001658247
Crinetics Pharmaceuticals, Inc. 已在 2026/9/1 下市；內部人最後一份 Form 4 在 2026/9/1 申報；2026 年第 2 季末有 267 家機構在 13F 申報持有，市值合計 $46.3 億；沒有大師持有。
持有 CRNX 5% 以上的大股東
最新一份 Schedule 13D 或 13G 申報持有 Crinetics Pharmaceuticals, Inc. 5% 以上的持有人，依持股比例由大到小；變化是跟這位持有人的上一份申報比。
| 持有人 | 最新表單 | 持股 | 變化 | 首次申報 | 最新申報 | 原文 |
|---|---|---|---|---|---|---|
| Farallon Capital Management, L.L.C. | 13G/A | 8.50%股數 898.9 萬 | – | 2026/8/31 份 | 2026/8/3 | SEC |
| Farallon Capital Partners, L.P. | 13G/A | 8.50%股數 802.4 萬 | +2.50 個百分點原本 6.00% | 2025/9/82 份 | 2026/2/5 | SEC |
| Wellington Management Group LLP | 13G/A | 6.80%股數 713.1 萬 | −1.00 個百分點原本 7.80% | 2023/2/68 份 | 2026/8/13 | SEC |
| Driehaus Capital Management LLC | 13G/A | 6.11%股數 639.6 萬 | – | 2022/1/104 份 | 2026/5/15 | SEC |
| Vanguard Capital Management LLC | 13G | 5.19%股數 544.1 萬 | 新申報 | 2026/4/291 份 | 2026/4/29 | SEC |
| Price T Rowe Associates Inc | 13G/A | 5.10%股數 535.5 萬 | – | 2024/11/142 份 | 2026/5/15 | SEC |
持股是每位持有人最新一份申報的數字。最後一份是舊格式（2024 年 12 月 18 日以前）的持有人沒有持股比例紀錄，不列在這裡；公司被收購或下市之後，持有人通常就不再申報。
13D 與 13G 申報
Crinetics Pharmaceuticals, Inc. 的 65 份 Schedule 13D、13G 申報，由新到舊，包括沒有持股比例的舊格式申報。
| 申報時間（美東） | 申報人 | 表單 | 持股 | 變化 | 事件日 | 原文 |
|---|---|---|---|---|---|---|
| 2022/2/11 | OrbiMed Advisors LLC | 13G/A舊制 | – | – | – | SEC |
| 2022/2/10 | Struthers Richard Scott | 13G/A舊制 | – | – | – | SEC |
| 2022/2/316:41 ET | BlackRock Inc. | 13G/A舊制 | – | – | – | SEC |
| 2022/1/10 | Driehaus Capital Management LLC | 13G舊制 | – | 新申報 | – | SEC |
| 2022/1/10 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2021/10/29 | Biotechnology Value Fund L P | 13G舊制 | – | 新申報 | – | SEC |
| 2021/4/22 | Deep Track Capital, LP | 13G舊制 | – | 新申報 | – | SEC |
| 2021/2/16 | Versant Venture Capital V, L.P. | 13G/A舊制 | – | – | – | SEC |
| 2021/2/16 | Ra Capital Management, L.P. | 13G/A舊制 | – | – | – | SEC |
| 2021/2/16 | 5AM Ventures IV, L.P. | 13G/A舊制 | – | – | – | SEC |
| 2021/2/12 | Vivo Capital VIII, LLC | 13G/A舊制 | – | – | – | SEC |
| 2021/2/12 | OrbiMed Advisors LLC | 13G/A舊制 | – | – | – | SEC |
| 2021/2/8 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2021/2/5 | Struthers Richard Scott | 13G/A舊制 | – | – | – | SEC |
| 2021/2/215:13 ET | BlackRock Inc. | 13G舊制 | – | 新申報 | – | SEC |
Form 144：內部人預計賣出
高階主管、董事與其他關係人預計賣出 Crinetics Pharmaceuticals, Inc. 股票的 77 份通知，由新到舊。
| 申報時間（美東） | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|
| 2026/7/216:31 ET | Jeff Knight高階主管 | 4.74 萬 | $183.4 萬 | 2026/7/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/7/216:29 ET | Rogerio Vivaldi Coelho董事 | 6,000 | $23.2 萬 | 2026/7/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/6/1716:27 ET | Stephanie Okey董事 | 6,900 | $24.1 萬 | 2026/6/1710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/5/416:26 ET | Jeff Knight高階主管 | 9,485 | $37.0 萬 | 2026/5/410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/4/1416:37 ET | Jeff Knight高階主管 | 2.09 萬 | $80.8 萬 | 2026/4/1410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/4/1316:36 ET | Jeff Knight高階主管 | 4,434 | $17.5 萬 | 2026/4/1310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/4/816:49 ET | Jeff Knight高階主管 | 8.52 萬 | $327.1 萬 | 2026/4/810b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/3/1816:30 ET | Dana Pizzuti高階主管 | 2.48 萬 | $93.8 萬 | 2026/3/1810b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/3/1609:24 ET | Jeff Knight高階主管 | 2.51 萬 | $94.1 萬 | 2026/3/16 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/3/1609:23 ET | Stephen Betz高階主管 | 2.65 萬 | $99.4 萬 | 2026/3/16 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/3/1609:23 ET | Richard Scott Struthers董事 · 高階主管 | 4.50 萬 | $168.8 萬 | 2026/3/16 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/3/1216:28 ET | Rogerio Vivaldi Coelho董事 | 5,000 | $18.5 萬 | 2026/3/1210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/3/316:32 ET | Stephanie S Okey董事 | 3,000 | $12.2 萬 | 2026/3/310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/3/210:28 ET | Tobin Schilke高階主管 | 6,800 | $28.0 萬 | 2026/3/2 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/2/216:32 ET | Dana Pizzuti高階主管 | 1.00 萬 | $49.9 萬 | 2026/2/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/1/516:43 ET | Isabel Kalofonos高階主管 | 2,500 | $11.7 萬 | 2026/1/510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/1/216:31 ET | Dana Pizzuti高階主管 | 5,000 | $23.3 萬 | 2026/1/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/12/116:37 ET | Dana Pizzuti高階主管 | 5,000 | $22.8 萬 | 2025/12/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/11/316:26 ET | Dana Pizzuti高階主管 | 5,000 | $21.8 萬 | 2025/11/310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/10/116:30 ET | Dana Pizzuti高階主管 | 5,000 | $20.8 萬 | 2025/10/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/9/2616:27 ET | Matthew K Fust董事 | 1.60 萬 | $57.4 萬 | 2025/9/2610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/9/2616:09 ET | Struthers Richard Scott高階主管 · 董事 | 4,000 | $18.0 萬 | 2025/9/2610b5-1 | UBS Financial Services Inc. | SEC |
| 2025/9/216:41 ET | Dana Pizzuti高階主管 | 5,000 | $15.5 萬 | 2025/9/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/8/2216:44 ET | Dana Pizzuti高階主管 | 3.00 萬 | $88.2 萬 | 2025/8/2210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/8/2016:24 ET | Dana Pizzuti高階主管 | 6,492 | $19.1 萬 | 2025/8/2010b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
只列最新的 25 份。看 CRNX 近 12 個月的全部通知